首页> 外国专利> PROPHYLAXIS OF POSTOPERATIVE PYOGENIC/SEPTIC ACCIDENTS IN PATIENTS SUFFERING FROM RECTAL CANCER

PROPHYLAXIS OF POSTOPERATIVE PYOGENIC/SEPTIC ACCIDENTS IN PATIENTS SUFFERING FROM RECTAL CANCER

机译:直肠癌患者术后脓毒症/脓毒症的预防性治疗

摘要

FIELD: medicine, in particular surgery, oncology.;SUBSTANCE: claimed method includes immunotherapy, namely on day before operation reaferonum-EC-lipint in dose of 1000-15000 U/kg is perorally administrated to patient. Then in postoperative period blood sampling, extracorporal incubation of leucocytes with imunofan, and intravenous drop administration are carried out. Further for 5 days after operation reaferonum-EC-lipint is perorally administrated to patient dose of 1000-15000 U/kg one time per day. Method of present invention may be used in treatment of patients after radiotherapy in postoperative period. Furthermore method makes it possible to decrease of therapy time by 1.6 times, to reduce total accident number by 2.3 times and decrease of mortality by 2 times.;EFFECT: improved method for rectal cancer treatment.;3 ex, 1 tbl
机译:领域:药物:要求保护的方法包括免疫疗法,即在手术前一天口服给予患者1000-15000 U / kg剂量的reaferonum-EC-lipint。然后在术后血液采样中,将白细胞与Imoofanan一起进行体外培养,并进行静脉内滴剂给药。术后5天,每天一次,以1000-15000U / kg的剂量经口给予利发隆-EC-利普林。本发明的方法可以用于术后期放射治疗后的患者的治疗。此外,该方法还可以减少1.6倍的治疗时间,减少2.3倍的总事故发生率和2倍的死亡率。效果:改进的直肠癌治疗方法。3ex,1 tbl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号